CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Halozyme prevails in patent fight with Merck; Enliven readies anticipated leukemia trial

Patent ExpiryEnliven drugPositive
AI Analysis

Summary

Halozyme won a patent dispute with Merck. Enliven is preparing to initiate a leukemia trial.

Clinical Trial Data

Outcome Details

Halozyme prevails in patent fight with Merck

Importance:5/10
Sentiment:
0.30
patentlitigationleukemiaclinical trial
Related Companies

Read the original article

Published by yahoo_finance on October 7, 2026 3:21 PM

Read Original